NAFLD is a complex disease, and its pathophysiology involves diverse aspects, including disturbances in glucose and lipid metabolism, lipotoxicity, insulin resistance, chronic inflammation, and disruptions in intestinal function and gut microbiome composition, etc (4). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.